The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.
Brugnolo, Francesca
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. [electronic resource] - The Journal of allergy and clinical immunology Feb 2003 - 380-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0091-6749
10.1067/mai.2003.102 doi
Adjuvants, Immunologic--pharmacology
Adult
Allergens
Ampicillin--adverse effects
Animals
Antigens, Dermatophagoides--immunology
Arthropod Proteins
Cell Line
Cysteine Endopeptidases
Cytokines--biosynthesis
Drug Hypersensitivity--immunology
Humans
Hypersensitivity, Immediate--immunology
Imidazoles--pharmacology
In Vitro Techniques
Interferon-gamma--biosynthesis
Models, Immunological
T-Lymphocyte Subsets--drug effects
Th1 Cells--drug effects
Th2 Cells--drug effects
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. [electronic resource] - The Journal of allergy and clinical immunology Feb 2003 - 380-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0091-6749
10.1067/mai.2003.102 doi
Adjuvants, Immunologic--pharmacology
Adult
Allergens
Ampicillin--adverse effects
Animals
Antigens, Dermatophagoides--immunology
Arthropod Proteins
Cell Line
Cysteine Endopeptidases
Cytokines--biosynthesis
Drug Hypersensitivity--immunology
Humans
Hypersensitivity, Immediate--immunology
Imidazoles--pharmacology
In Vitro Techniques
Interferon-gamma--biosynthesis
Models, Immunological
T-Lymphocyte Subsets--drug effects
Th1 Cells--drug effects
Th2 Cells--drug effects